Found: 33
Select item for more details and to access through your institution.
A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase II Study of Bortezomib and Pegylated Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 465, doi. 10.3816/CBC.2010.n.061
- By:
- Publication type:
- Article
Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 196, n. 1, p. 153, doi. 10.1007/s10549-022-06700-6
- By:
- Publication type:
- Article
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 3, p. 623, doi. 10.1007/s10549-020-05603-8
- By:
- Publication type:
- Article
Body mass index and patient-reported function, quality of life and treatment toxicity in women receiving adjuvant chemotherapy for breast cancer.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 3, p. 1, doi. 10.1007/s00520-023-07637-2
- By:
- Publication type:
- Article
First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1047, doi. 10.1007/s10637-021-01081-x
- By:
- Publication type:
- Article
Nanoparticle-Delivered Chemotherapy: Old Drugs in New Packages.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 3, p. 198
- By:
- Publication type:
- Article
Quantifying the recruitment challenges with couple-based interventions for cancer: applications to early-stage breast cancer.
- Published in:
- Psycho-Oncology, 2009, v. 18, n. 6, p. 667, doi. 10.1002/pon.1477
- By:
- Publication type:
- Article
The interaction of post-traumatic growth and post-traumatic stress symptoms in predicting depressive symptoms and quality of life.
- Published in:
- Psycho-Oncology, 2008, v. 17, n. 9, p. 948, doi. 10.1002/pon.1313
- By:
- Publication type:
- Article
Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 9, p. 777, doi. 10.1007/s00262-004-0520-1
- By:
- Publication type:
- Article
Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16<sup>INK4a</sup>.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 6, p. 1, doi. 10.1093/jncics/pkaa082
- By:
- Publication type:
- Article
Risk Perceptions and Psychosocial Outcomes of Women With Ductal Carcinoma In Situ: Longitudinal Results From a Cohort Study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 4, p. 243, doi. 10.1093/jnci/djn010
- By:
- Publication type:
- Article
American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Pilot study of rosiglitazone as an in vivo probe of paclitaxel exposure.
- Published in:
- British Journal of Clinical Pharmacology, 2012, v. 74, n. 1, p. 197, doi. 10.1111/j.1365-2125.2012.04165.x
- By:
- Publication type:
- Article
A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8172, doi. 10.1002/cam4.5619
- By:
- Publication type:
- Article
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.810023
- By:
- Publication type:
- Article
INNV-35. ROUTINE SEQUENCING OF BRAIN TUMORS UNCOVERS HIGH RATES OF ACTIONABLE OPPORTUNITIES: THE UNC EXPERIENCE.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi145, doi. 10.1093/neuonc/noy148.606
- By:
- Publication type:
- Article
A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin.
- Published in:
- Annals of Hematology, 2007, v. 86, n. 3, p. 211, doi. 10.1007/s00277-006-0220-3
- By:
- Publication type:
- Article
The effects of lapatinib on CYP3A metabolism of midazolam in patients with advanced cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 117, doi. 10.1007/s00280-014-2474-0
- By:
- Publication type:
- Article
A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 63, n. 1, p. 99, doi. 10.1007/s00280-008-0716-8
- By:
- Publication type:
- Article
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane<sup>®</sup>) on three treatment schedules in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 5, p. 759, doi. 10.1007/s00280-007-0423-x
- By:
- Publication type:
- Article
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumors.
- Published in:
- 2007
- By:
- Publication type:
- journal article
The warfarin--cranberry juice interaction revisited: A systematic in vitro--in vivo evaluation.
- Published in:
- Journal of Experimental Pharmacology, 2010, v. 2, p. 83
- By:
- Publication type:
- Article
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00500-3
- By:
- Publication type:
- Article
A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00473-3
- By:
- Publication type:
- Article
A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience.
- Published in:
- Oncologist, 2016, v. 21, n. 1, p. 16, doi. 10.1634/theoncologist.2015-0328
- By:
- Publication type:
- Article
Phase I Study and Biomarker Analysis of Lapatinib and Concurrent Radiation for Locally Advanced Breast Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 12, p. 1496, doi. 10.1634/theoncologist.2012-0256
- By:
- Publication type:
- Article
Patient‐reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 957, doi. 10.1002/cncr.33329
- By:
- Publication type:
- Article
Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute.
- Published in:
- 2016
- By:
- Publication type:
- journal article